Pacira Good Will from 2010 to 2024

PCRX Stock  USD 17.38  0.35  2.06%   
Pacira BioSciences, Good Will yearly trend continues to be fairly stable with very little volatility. Good Will is likely to outpace its year average in 2024. Good Will is an intangible asset that arises when Pacira BioSciences, acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors. View All Fundamentals
 
Good Will  
First Reported
2011-06-30
Previous Quarter
163.2 M
Current Value
163.2 M
Quarterly Volatility
56.1 M
 
Yuan Drop
 
Covid
Check Pacira BioSciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacira BioSciences,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 79.4 M, Interest Expense of 15.8 M or Selling General Administrative of 63.1 M, as well as many indicators such as Price To Sales Ratio of 2.19, Dividend Yield of 0.0014 or PTB Ratio of 1.7. Pacira financial statements analysis is a perfect complement when working with Pacira BioSciences, Valuation or Volatility modules.
  
Check out the analysis of Pacira BioSciences, Correlation against competitors.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.

Latest Pacira BioSciences,'s Good Will Growth Pattern

Below is the plot of the Good Will of Pacira BioSciences, over the last few years. It is an intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors. Pacira BioSciences,'s Good Will historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pacira BioSciences,'s overall financial position and show how it may be relating to other accounts over time.
Good Will10 Years Trend
Slightly volatile
   Good Will   
       Timeline  

Pacira Good Will Regression Statistics

Arithmetic Mean75,306,492
Geometric Mean0.00
Coefficient Of Variation92.10
Mean Deviation58,735,790
Median55,197,000
Standard Deviation69,358,268
Sample Variance4810.6T
Range197.1M
R-Value0.97
Mean Square Error333.8T
R-Squared0.94
Slope15,001,076
Total Sum of Squares67348T

Pacira Good Will History

2024197.1 M
2023187.7 M
2022163.2 M
2021145.2 M
201999.5 M
201862 M
201755.2 M

About Pacira BioSciences, Financial Statements

Pacira BioSciences, investors use historical fundamental indicators, such as Pacira BioSciences,'s Good Will, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pacira BioSciences,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Good Will187.7 M197.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.